Synopsis
Synopsis
0
JDMF
0
KDMF
0
VMF
0
Australia
0
South Africa
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. Acetyl Methylprednisolone
2. Acetyl-methylprednisolone
3. Depo Medrol
4. Depo Medrone
5. Depo-medrol
6. Depo-medrone
7. Methylprednisolone 21 Acetate
8. Methylprednisolone Acetate, (11beta,16alpha)-isomer
9. Methylprednisolone Acetate, (11beta,16beta)-isomer
10. Methylprednisolone-21-acetate
1. Depo-medrol
2. 53-36-1
3. M-predrol
4. Depo-medrate
5. Medrol Acetate
6. Depo-medrone
7. Methylprednisolone 21-acetate
8. Depometicort
9. Depomedrone
10. Mepred
11. Medrol Enpak
12. Depo-medrin
13. 6alpha-methylprednisolone Acetate
14. D-med
15. Urbason Crystal Suspension
16. Depo-methylprednisolone Acetate
17. 6alpha-methylprednisolone 21-acetate
18. Depmedalone 40
19. Depmedalone 80
20. Methyl Prednisolone Acetate
21. U 8210
22. 11beta,17,21-trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione 21-acetate
23. Nsc-48985
24. 6alpha-methyl Prednisolone 21-acetate
25. Chebi:6889
26. Nsc 48985
27. 43502p7f0p
28. Depo-methylprednisolone
29. Unidrol
30. Lemod Depo
31. (6alpha,11beta)-11,17-dihydroxy-6-methyl-3,20-dioxopregna-1,4-dien-21-yl Acetate
32. Solsolona [inj.]
33. Ubrason [inj.]
34. [2-[(6s,8s,9s,10r,11s,13s,14s,17r)-11,17-dihydroxy-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6h-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] Acetate
35. Depot-medrol
36. Solsolona
37. Ubrason
38. Mls002667229
39. Einecs 200-171-3
40. 6-methylprednisolone Acetate
41. 6.alpha.-methylprednisolone Acetate
42. Unii-43502p7f0p
43. 6.alpha.-methylprednisolone 21-acetate
44. Ncgc00159503-02
45. Pregna-1,4-diene-3,20-dione, 21-(acetyloxy)-11,17-dihydroxy-6-methyl-, (6.alpha.,11.beta.)-
46. Depo-medrol (tn)
47. Methylprednisolone Acetate [usp:jan]
48. Component Of Neo-medrol
49. Dsstox_cid_3302
50. Methylprednisolon-21-acetat
51. Dsstox_rid_76966
52. Pregna-1,4-diene-3,20-dione, 21-(acetyloxy)-11,17-dihydroxy-6-methyl-, (6-alpha,11-beta)-
53. Pregna-1,4-diene-3,20-dione, 21-(acetyloxy)-11,17-dihydroxy-6-methyl-, (6alpha,11beta)-
54. Dsstox_gsid_23302
55. Schembl13231
56. Mls001304003
57. Methyl Prednisolone 21-acetate
58. Chembl1364144
59. Dtxsid7023302
60. Methylprednisolone Ep Impurity J
61. 11.beta.,17,21-trihydroxy-6.alpha.-methylpregna-1,4-diene-3,20-dione 21-acetate
62. Bdbm233194
63. Hms2233n14
64. Hms3259l07
65. Nsc48985
66. 6?-methyl Prednisolone 21-acetate
67. Tox21_111722
68. S5973
69. Methylprednisolone Acetate (jan/usp)
70. Akos015969745
71. Zinc118912449
72. Nc00628
73. 6 Alpha -methylprednisolone 21-acetate
74. Cas-53-36-1
75. Methylprednisolone Acetate [jan]
76. Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl-, 21-acetate
77. Hy-13681
78. Methylprednisolone Acetate [mart.]
79. Methylprednisolone Acetate [vandf]
80. Smr000718757
81. Methylprednisolone Acetate [usp-rs]
82. Methylprednisolone Acetate [who-dd]
83. Cs-0007549
84. M2635
85. C08179
86. D00979
87. D87728
88. Methylprednisolone Acetate [green Book]
89. Methylprednisolone Acetate [orange Book]
90. Ab00375925-05
91. Methylprednisolone Acetate [ep Monograph]
92. Methylprednisolone Acetate [usp Impurity]
93. Methylprednisolone Acetate For Peak Identification
94. Methylprednisolone Acetate For System Suitability
95. 200m356
96. Methylprednisolone Acetate [usp Monograph]
97. Methylprednisolone Impurity J [ep Impurity]
98. Methylprednisolone Acetate 100 Microg/ml In Methanol
99. Q27107351
100. Neo-medrol Acetate Component Methylprednisolone Acetate
101. Methylprednisolone Acetate Component Of Neo-medrol Acetate
102. Methylprednisolone Hydrogen Succinate Impurity C [ep Impurity]
103. Pregna-1,20-dione, 11.beta.,17,21-trihydroxy-6.alpha.-methyl-, 21-acetate
104. Pregna-1,20-dione, 21-(acetyloxy)-11,17-dihydroxy-6-methyl-, (6.alpha.,11.beta.)-
105. Methylprednisolone Acetate; 6?-methyl Prednisolone 21-acetate; Methylprednisolone Hydrogen Succinate Ep Impurity C; 11?,17-dihydroxy-6?-methyl-3,20-dioxopregna-1,4-dien21-yl Acetate; 21-acetoxy-11?,17-dihydroxy-6?-methylpregna-1,4-diene-3,20-dione
Molecular Weight | 416.5 g/mol |
---|---|
Molecular Formula | C24H32O6 |
XLogP3 | 2.7 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 4 |
Exact Mass | 416.21988874 g/mol |
Monoisotopic Mass | 416.21988874 g/mol |
Topological Polar Surface Area | 101 Ų |
Heavy Atom Count | 30 |
Formal Charge | 0 |
Complexity | 858 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 8 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
1 of 4 | |
---|---|
Drug Name | Depo-medrol |
Drug Label | DEPO-MEDROL is an anti-inflammatory glucocorticoid for intramuscular, intra-articular, soft tissue, or intralesional injection. It is available in three strengths: 20 mg/mL; 40 mg/mL; 80 mg/mL.Each mL of these preparations contains:Methylprednisolone... |
Active Ingredient | Methylprednisolone acetate |
Dosage Form | Injectable |
Route | Injection |
Strength | 20mg/ml; 80mg/ml; 40mg/ml |
Market Status | Prescription |
Company | Pharmacia And Upjohn |
2 of 4 | |
---|---|
Drug Name | Methylprednisolone acetate |
Drug Label | DEPO-MEDROL is an anti-inflammatory glucocorticoid for intramuscular, intra-articular, soft tissue, or intralesional injection. It is available in three strengths: 20 mg/mL; 40 mg/mL; 80 mg/mL.Each mL of these preparations contains:Methylprednisolone... |
Active Ingredient | Methylprednisolone acetate |
Dosage Form | Injectable |
Route | Injection |
Strength | 80mg/ml; 40mg/ml |
Market Status | Prescription |
Company | Teva Pharms Usa; Sandoz |
3 of 4 | |
---|---|
Drug Name | Depo-medrol |
Drug Label | DEPO-MEDROL is an anti-inflammatory glucocorticoid for intramuscular, intra-articular, soft tissue, or intralesional injection. It is available in three strengths: 20 mg/mL; 40 mg/mL; 80 mg/mL.Each mL of these preparations contains:Methylprednisolone... |
Active Ingredient | Methylprednisolone acetate |
Dosage Form | Injectable |
Route | Injection |
Strength | 20mg/ml; 80mg/ml; 40mg/ml |
Market Status | Prescription |
Company | Pharmacia And Upjohn |
4 of 4 | |
---|---|
Drug Name | Methylprednisolone acetate |
Drug Label | DEPO-MEDROL is an anti-inflammatory glucocorticoid for intramuscular, intra-articular, soft tissue, or intralesional injection. It is available in three strengths: 20 mg/mL; 40 mg/mL; 80 mg/mL.Each mL of these preparations contains:Methylprednisolone... |
Active Ingredient | Methylprednisolone acetate |
Dosage Form | Injectable |
Route | Injection |
Strength | 80mg/ml; 40mg/ml |
Market Status | Prescription |
Company | Teva Pharms Usa; Sandoz |
Anti-Inflammatory Agents
Substances that reduce or suppress INFLAMMATION. (See all compounds classified as Anti-Inflammatory Agents.)
Date of Issue : 2022-07-05
Valid Till : 2025-07-02
Written Confirmation Number : WC-0161A2
Address of the Firm :
NDC Package Code : 22552-0023
Start Marketing Date : 2011-08-08
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
Gonane has API manufacturing expertise in new-age Corticosteroids, Hormones and other pharma raw materials.
GDUFA
DMF Review : Reviewed
Rev. Date : 2014-06-23
Pay. Date : 2013-12-31
DMF Number : 27325
Submission : 2013-07-19
Status : Active
Type : II
Certificate Number : R0-CEP 2021-429 - Rev 00
Issue Date : 2023-06-23
Type : Chemical
Substance Number : 933
Status : Valid
NDC Package Code : 46439-8767
Start Marketing Date : 2018-11-15
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Available Reg Filing : EU |
NDC Package Code : 82298-117
Start Marketing Date : 2011-02-07
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Available Reg Filing : ROW |
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3452
Submission : 1979-02-08
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 24611
Submission : 2011-02-03
Status : Active
Type : II
Certificate Number : R1-CEP 2011-063 - Rev 01
Issue Date : 2021-05-12
Type : Chemical
Substance Number : 933
Status : Valid
Date of Issue : 2022-09-30
Valid Till : 2025-07-02
Written Confirmation Number : WC-0161
Address of the Firm :
NDC Package Code : 22552-0023
Start Marketing Date : 2011-08-08
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
Date of Issue : 2022-08-31
Valid Till : 2025-07-02
Written Confirmation Number : WC-0162
Address of the Firm :
NDC Package Code : 22552-0023
Start Marketing Date : 2011-08-08
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 2688
Submission : 1976-05-24
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 415
Submission : 1960-12-21
Status : Inactive
Type : II
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?